Indian pharma lags on digital adoption: EY

Indian pharmaceutical companies lag their global peers in digital adoption, and less than 10 per cent of them have a comprehensive strategy in place, a study by EY has revealed.

While Indian drug makers have armed medical representatives with mobile apps and tablets, the use of digital tools to gain customer insight, stakeholder engagement and disease management is limited.

EY surveyed drug firms and hospital chains in the country and found over half of them were in the beginners’ stage, which meant that there was either no strategy in place or use of digital technology was limited for interaction between